doi: 10.1136/jcp.2004.022681 89 LandeAFlugeStrandEBFlmSTSosaDDMellaOet al
Abstract There is a current need for a therapy that can alleviate the social and economic burden that presents itself with debilitating and recurring musculoskeletal soft tissue injuries and disorders
In vitro and preclinical literature may discuss cell proliferation, pathway models, or experimental endpoints, but those findings should stay tied to the model being studied
4 In a follow-up study, researchers found that supplementing with vitamins B12 and B9 (folic acid) may increase the risk of colon cancer
If indicator levels rise above the standards, analysts use specialized methods to identify which harmful organisms are present
Recalls & Warnings September 12, 2012 Distribution of Weight Loss Product Containing DMAA Should Be Stopped Immediately, Warns FDA On August 28, 2012, the FDA issued a warning letter to Regeneca stating that the company's RegeneSlim, which was promoted as a dietary supplement for weight loss, is adulterated with dimethylamylamine (DMAA) and that failure to immediately cease distribution of this product could result in FDA